Harnessing the Science of Immuno-oncology at Novartis
Our immuno-oncology researchers are rapidly making discoveries about how cancers trip up our immune systems. Potential medicines that we’re developing aim put our immune systems back in control. © 2016Novartis AG
▶︎
Molecular pathways:The future of research at NIBR
▶︎
A guide to new medicines approval
▶︎
The Role of Interleukin-1 (IL-1) in Two Rare Autoinflammatory Diseases
▶︎
Novartis Strategy & Growth Update
▶︎
The mTOR pathway in ER+ advanced breast cancer
▶︎
Talking culture transformation with Vas Narasimhan and Adam Grant
▶︎
Meet Our People: Deepa Xavier
▶︎
The science behind CAR-T cell therapy
▶︎
Drug discovery and development process
▶︎
The journey of medical research
▶︎
Meet our people: Vas Narasimhan
▶︎
How Chronic Spontaneous Urticaria affected more than just her skin
▶︎
Next Generation Scientist 2025
▶︎
Meet Paula: Quality control for CAR-T manufacturing
▶︎
Leaders Never Go Alone: Vas Narasimhan in conversation with Jennifer Garvey Berger
▶︎
Periodic fever syndromes
▶︎
A gene therapy platform for treating diseases
▶︎
Vas Narasimhan at the 2019 One Young World Summit
▶︎